Cart
sales@molnova.com
Brimonidine Tartrate
CAS No. 70359-46-5
Brimonidine Tartrate ( AGN 190342LF; Alphagan P )
Catalog No. M15704 CAS No. 70359-46-5
Brimonidine Tartrate is a highly selective α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, and used to treat open-angle glaucoma or ocular hypertension.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 500MG | 113 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrimonidine Tartrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrimonidine Tartrate is a highly selective α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, and used to treat open-angle glaucoma or ocular hypertension.
-
DescriptionBrimonidine Tartrate is a highly selective α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, and used to treat open-angle glaucoma or ocular hypertension.
-
SynonymsAGN 190342LF; Alphagan P
-
PathwayEndocrinology/Hormones
-
TargetAdrenergic Receptor
-
Recptorα2A-adrenergic receptor
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number70359-46-5
-
Formula Weight442.22
-
Molecular FormulaC15H16BrN5O6
-
Purity>98%(HPLC)
-
SolubilityWater: 75 mg/mL (169.59 mM); DMSO: 88 mg/mL (198.99 mM)
-
SMILESC1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.WoldeMussie E, et al. Invest Ophthalmol Vis Sci, 2001, 42(12), 2849-2855.
molnova catalog
related products
-
Tetryzoline
Tetrahydrozoline is an alpha agonist and its main mechanism of action is the constriction of conjunctival blood vessels.
-
Carvedilol
Carvedilol(BM14190) is a non-selective beta blocker/alpha-1 blocker with an IC50 of 3.8 μM for inhibition of LDL oxidation.
-
Formoterol
Formoterol is a novel highly β2-selective adrenergic agonist and holds promise as a β2-agonist that could impart selective beneficial metabolic effects.
